Archives of gynecology and obstetrics · 2025
Functional hypothalamic amenorrhea (FHA) in women with normal body mass index (BMI): metabolic and hormonal profiles.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Barouka Daryna, Kacalska-Janssen Olga, Jach Robert, Piróg Magdalena
Аннотация
OBJECTIVES: To determine metabolic and hormonal profiles in women with functional hypothalamic amenorrhea (FHA) with normal body mass index (BMI).
METHODS: In FHA (n = 69) and controls (n = 69), matched for age and BMI lipid, fasting plasma glucose (FPG) and insulin (Ins) levels along with hormonal profile were determined.
RESULTS: FHA showed slightly lower FPG (- 8.2%, p = 0.001) contrary to the controls with no differences in lipid profile. In the FHA group, BMI was positively correlated with Ins (r = 0.57, p < 0.001) and negatively with high-density lipoprotein cholesterol (HDL-C; r = - 0.58, p < 0.001). Regarding hormonal profile, FHA showed higher prolactin (PRL; + 61.6%) and thyroid-stimulating hormone (TSH; + 4.0%) levels compared to the controls (all p < 0.05). FHA had higher androgen levels reflected by higher total testosterone (TT; + 22.2%) and 17-hydroxyprogesterone (17-OHP; + 88.9%) levels (all p < 0.05) in contrary to the remainder.
CONCLUSION: FHA women with normal BMI present unfavorably altered hormonal profile reflected by hyperandrogenemia and slightly lower, but significant, FPG level. The findings confirm the importance of assessing both metabolic and hormonal panels in FHA women despite normal BMI.
METHODS: In FHA (n = 69) and controls (n = 69), matched for age and BMI lipid, fasting plasma glucose (FPG) and insulin (Ins) levels along with hormonal profile were determined.
RESULTS: FHA showed slightly lower FPG (- 8.2%, p = 0.001) contrary to the controls with no differences in lipid profile. In the FHA group, BMI was positively correlated with Ins (r = 0.57, p < 0.001) and negatively with high-density lipoprotein cholesterol (HDL-C; r = - 0.58, p < 0.001). Regarding hormonal profile, FHA showed higher prolactin (PRL; + 61.6%) and thyroid-stimulating hormone (TSH; + 4.0%) levels compared to the controls (all p < 0.05). FHA had higher androgen levels reflected by higher total testosterone (TT; + 22.2%) and 17-hydroxyprogesterone (17-OHP; + 88.9%) levels (all p < 0.05) in contrary to the remainder.
CONCLUSION: FHA women with normal BMI present unfavorably altered hormonal profile reflected by hyperandrogenemia and slightly lower, but significant, FPG level. The findings confirm the importance of assessing both metabolic and hormonal panels in FHA women despite normal BMI.